Google has started testing its medical AI chatbot, Med-PaLM 2, in US hospitals, including the Mayo Clinic research hospital. The chatbot designed to answer medical questions is based on Google's PaLM 2, which was announced at Google I/O in May this year, Wall Street Journal reported. The chatbot is a variant of the PaLM 2 language model that is specifically tailored for medical institutions.
It is the same language model that also powers Google Bard, the AI chatbot that is currently available as an experiment to Google users.
-
Paris Setback, Asian Games Glory: Lovlina Borgohain's New Perspective -
To PM Modi's "Failed Product" Jab At Rahul Gandhi, A Shashi Tharoor Counter -
NDTV World Summit 2026: AI, Chips, Warfare And The Future Of The World | Key Conversations -
Kriti Sanon On Situationships, Open Relationships And Being Old-School -
'AI Scares Me': Kriti Sanon On Personality Rights And Need For Laws -
'AI Scares Me': Kriti Sanon On Personality Rights And Need For Laws -
'This Time I Wanted Gold': Savita Punia Reflects On Historic Asiad Success -
Favourite Bollywood Actor To 5-Year Plan, Kriti Sanon Interviews AI Actor Tilly Norwood -
Neeru Dhanda Carried Homemade Churma To Asiad, Returned With Two Gold Medals -
Inside The Mind Of Archer Kumkum Mohod, Who Dared To Challenge South Korea
As per the report, the AI chatbot has been in use since April which aims to answer medical queries and facilitate conversations on health-related matters. The chatbot is trained on a curated set of medical expert demonstrations to improve its healthcare conversation capabilities better than generalized chatbots like Bard, Bing, and ChatGPT.
Med-PaLM 2 will collect data from users testing it but it will be encrypted and Google will not have access to it.
According to an internal mail accessed by WSJ, Google believes its updated model can be particularly helpful in countries with ''more limited access to doctors.''
However, physicians found more inaccuracies and irrelevant information in the answers provided by Med-PaLM 2 compared to those provided by other doctors.
A senior researcher who worked on the project was quoted as saying the company is still in the early stages of developing the product.
Senior research director Greg Corrado, said that while he wouldn't want it to be a part of his own family's ''healthcare journey,'' he believes Med-PaLM 2 ''takes the places in healthcare where AI can be beneficial and expands them by 10-fold.''
Track Latest News Live on NDTV.com and get news updates from India and around the world